Neostigmine and Edrophonium Antagonism of Varying Intensity Neuromuscular Blockade Induced by Atracurium, Pancuronium, or Vecuronium
Open Access
- 1 June 1986
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 64 (6) , 711-717
- https://doi.org/10.1097/00000542-198606000-00006
Abstract
To compare the time course of neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium, the authors studied 98 patients anesthetized with nitrous oxide (60%) and halothane or enflurane. Neuromuscular blockade, as monitored by single stimulus-induced twitch tension (TT), was antagonized at varying degrees of spontaneous recovery (2-80% of control TT). Time to antagonism (time from injection of neostigmine or edrophonium to 90% recovery of control TT) was not different between edrophonium, 0.5 mg/kg, and neostigmine, 0.04 mg/kg, when spontaneous recovery had been allowed to occur to at least 11% of control TT prior to antagonist administration (P > 0.05). For profound neuromuscular blockade (TT .ltoreq. 10% of control) induced by pancuronium or vecuronium, time (mean .+-. SD) to antagonism with neostigmine, 0.04 mg/kg, was 7.0 .+-. 2.2 min and 5.6 .+-. 1.7 min, respectively, while the same for edrophonium, 0. 5mg/kg, was 20.0 .+-. 8.0 min and 15.0 .+-. 12.5 min, respectively (P < 0.05). Time to antagonism of profound atracurium-induced neuromuscular blockade was 8.5 .+-. 3.3 min for neostigmine, 0.04 mg/kg, and 9.8 .+-. 7.0 min for edrophonium, 0.5 mg/kg, (P > 0.05). For profound vecuronium- and pancuronium-induced neuromuscular blockade, time to antagonism by edrophonium, 1.0 mg/kg, was 4.6 .+-. 3.0 min and 3.9 .+-. 1.6 min respectively. The authors conclude that neostigmine, 0.04 mg/kg, antagonizes neuromuscular blockade within 12 min when TT is greater than 2% of control at time of reversal. When TT is greater than 10% of control, edrophonium, 0.5 mg/kg, produces similar time to antagonism. However, when TT is 2-10% of control, the dose of edrophonium dose should be at least 1.0 mg/kg to be as rapid as neostigmine, 0.04 mg/kg.This publication has 11 references indexed in Scilit:
- The Pharmacokinetics and Pharmacodynamics of Atracurium in Patients with and without Renal FailureAnesthesiology, 1984
- Pharmacokinetics and Pharmacodynamics of Vecuronium (ORG NC45) and Pancuronium in Anesthetized HumansAnesthesiology, 1983
- EdrophoniumAnesthesiology, 1982
- IMPAIRED NEOSTIGMINE ANTAGONISM OF PANCURONIUM DURING ENFLURANE ANAESTHESIA IN MANBritish Journal of Anaesthesia, 1982
- SOME ACTIONS OF ORG NC45 AND OF EDROPHONIUM IN THE ANAESTHETIZED CAT AND IN MANBritish Journal of Anaesthesia, 1982
- Pharmacokinetics of Edrophonium and Neostigmine When Antagonizing d-Tubocurarine Neuromuscular Blockade in ManAnesthesiology, 1981
- Twitch, Tetanus and Train-of-Four as Indices of Recovery from Nondepolarizing Neuromuscular BlockadeAnesthesiology, 1981
- Neostigmine, Pyridostigmine, and Edrophonium as Antagonists of PancuroniumAnesthesiology, 1980
- Edrophonium Antagonism of Pancuronium-induced Neuromuscular Blockade in ManAnesthesiology, 1979
- Neuromuscular Effects of d-Tubocurarine, Edrophonium and Neostigmine in ManAnesthesiology, 1967